Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Singh, Pravin K. ; Jain, Amita
• Description:
  Resistance to second-line tuberculosis drugs for patients with multidrug-resistant tuberculosis has emerged globally and is a potential risk factor for unfavorable outcomes of shorter duration drug regimens. We assessed the proportion of patients eligible for a shorter drug regimen in Uttar Pradesh, India, which had the highest rate of multidrug-resistant tuberculosis in India.
• Subjects:
  Antimicrobial Resistance Bacteria Fluoroquinolone Limited Scope Of Shorter Drug Regimen For MDR TB Caused By High Resistance To Fluoroquinolone Line-probe Assay MDR TB Multidrug-resistant Tuberculosis Research Letter Respiratory Infections Rifampin Second-line Drugs Shorter Regimen TB Tuberculosis Tuberculosis And Other Mycobacteria

  More +
• Source:
  Emerg Infect Dis. 25(9):1760-1762
• Pubmed ID:
  31441763
• Pubmed Central ID:
  PMC6711219
• Document Type:
  Journal Article
• Place as Subject:
  India
• Location:
  Asia
• Volume:
  25
• Issue:
  9
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:26c98385a60811c2aef269125ddbc22d9303b5eea07277062865c95e75cf27a7
• Download URL:
  https://stacks.cdc.gov/view/cdc/81160/cdc_81160_DS1.pdf
• File Type:
  [PDF - 427.60 KB ]